Swire Pacific B (00087) spent 1.86 million Hong Kong dollars on repurchasing 187,500 shares on September 20th.
The announcement was made by TAIGU Holdings Company B (00087) on September 20, 2024, stating that the company had invested 186.08...
SWIRE PACIFIC B (00087) announced that the company has repurchased 187,500 shares at a total cost of HK$1.8608 million on September 20, 2024, with a repurchase price ranging from HK$9.76 to HK$9.97 per share.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH) signed a licensing agreement with Novo Nordisk A/S for the HRS-1596 project.
HARBIN BANK (06138) Enhances and Expands Agricultural Services to Support High-Quality Development of Agriculture in Heilongjiang
Jiangsu Hengrui Pharmaceuticals (01276) licenses exclusive overseas rights to HRS-1596 to Novo, with a potential transaction value of up to US$2.6 billion.
Jiangsu Hengrui Pharmaceuticals (600276.SH) signed a licensing agreement with Novo Nordisk A/S for the HRS-1596 project.
HARBIN BANK (06138) Enhances and Expands Agricultural Services to Support High-Quality Development of Agriculture in Heilongjiang
Jiangsu Hengrui Pharmaceuticals (01276) licenses exclusive overseas rights to HRS-1596 to Novo, with a potential transaction value of up to US$2.6 billion.
